Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 639-648, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huijgen, H. J.
Right arrow Articles by Sanders, G. T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huijgen, H. J.
Right arrow Articles by Sanders, G. T. B.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Nutrition
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 1998;44:639-648.)
© 1998 American Association for Clinical Chemistry, Inc.

General Clinical Chemistry

Intracellular and extracellular blood magnesium fractions in hemodialysis patients; is the ionized fraction a measure of magnesium excess?

Henk J. Huijgen1, Renata Sanders1, Rudolf W. van Olden2, Marjolein G. Klous1, Faryal R. Gaffar1, and Gerard T. B. Sanders1

1 Academic Medical Center, University of Amsterdam, Departments of Clinical Chemistry and
2 Nephrology, F1–217, P.O. Box 22700, Amsterdam, 1100 DE, The Netherlands.

3 The work reported here was performed by Renata Sanders, Marjolein G. Klous, Henk J. Huijgen, Rudolf W. van Olden, and Gerard T.B. Sanders, with grateful appreciation for the technical assistance of Ron Hoebe and Carel van Oven of the Department of Radiobiology of the University of Amsterdam. Address correspondence about the Appendix to R.S. Fax 31-20-5664440.
a Author for correspondence. Fax 31-20-5664440; e-mail h.huijgen{at}amc.uva.nl.

To establish the best measure for determining magnesium overload, we measured ionized and total magnesium in serum and mononuclear blood cells and total magnesium in erythrocytes in blood of 23 hemodialysis patients, known for their disturbed magnesium homeostasis. When comparing the mean magnesium values obtained in the patient population with those of a control population, all of these magnesium markers, including the biologically active fractions, were significantly (P <0.05) increased. Because serum total magnesium was not increased in all dialysis patients studied, the population was divided into two groups, according to total serum magnesium >1.0 mmol/L or less than that. Results in these two populations showed that ionized serum magnesium and ionized magnesium in mononuclear blood cells might give a better indication about the magnesium status of the tested patients than the currently used total serum magnesium data. However, neither of the two markers, especially ionized serum magnesium, was able to discriminate fully between normal magnesium homeostasis and magnesium excess. We therefore conclude that the two ionized magnesium markers offer minimal advantage for this discrimination, and that the total magnesium concentration in serum remains the measurement of choice.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.